Krystal Biotech, Inc. Income Statement

Income Statement Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue -1.49M50.70M290.51M
Cost of Revenue 3.09M20.06M
Gross Profit -1.49M47.61M270.45M
Operating items
Research & Development 17.94M27.88M42.46M46.43M53.57M
Selling, General & Administrative 15.06M40.39M77.73M98.40M113.69M
Restructuring Costs 25.00M12.50M37.50M
Other Operating Expenses 100.00M20.06M
Operating Expenses 33.00M68.28M145.20M160.43M224.82M
Operating Income -33.00M-68.28M-145.20M-109.73M65.69M
EBIT -33.00M-68.28M-145.20M-109.73M65.69M
Non-operating items
Interest & Investment Income 0.83M0.20M5.22M22.62M29.66M
Net income details
EBT -32.17M-69.57M-139.97M12.90M95.36M
Tax Provisions 1.97M6.20M
Profit After Tax -32.17M-69.57M-139.97M10.93M89.16M
Income from Continuing Operations -32.17M-69.57M-139.97M10.93M89.16M
Consolidated Net Income -32.17M-69.57M-139.97M10.93M89.16M
Income towards Parent Company -32.17M-69.57M-139.97M10.93M89.16M
Net Income towards Common Stockholders -32.17M-69.57M-139.97M10.93M89.16M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M0.00M0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M0.00M0.00M
Shares Outstanding (Weighted Average) 10.24M14.43M17.31M19.71M22.24M25.75M28.29M28.76M
Shares Outstanding (Diluted Average) 22.20M25.49M27.75M29.74M
EBITDA -32.17M-69.74M-140.54M12.30M88.33M
Tax Rate 15.24%6.50%